BeiGene
BGNE
#1074
Rank
$16.94 B
Marketcap
$156.11
Share price
0.37%
Change (1 day)
-16.03%
Change (1 year)
BeiGene is a Chinese pharmaceutical company engaged in the R&D, and commercialization of molecularly-targeted, and immuno-oncology drugs for the treatment of cancer.

BeiGene (BGNE) - Cost to borrow shares

Latest borrow fee for BeiGene (BGNE) shares on Interactive Brokers: 0.4030% (annualized)

Shares available to borrow: 100000
The cost to borrow / borrow fee is an annualized percentage an account is charged when borrowing shares of a stock.
Please note that the borrow fee and available shares to borrow displayed on this page are solely based on information provided by Interactive Brokers.

BeiGene (BGNE) - cost to borrow in the last 7 days chart

BeiGene (BGNE) - number of shares available to borrow in the last 7 days

BeiGene (BGNE) - cost to borrow from 2024 to 2023

BeiGene (BGNE) - number of shares available to borrow from 2024 to 2023

Cost to borrow for shares of similar companies or competitors

Company Cost to borrow (% year) Shares available Country
6.0146%0.3 M๐Ÿ‡บ๐Ÿ‡ธ USA
15.3779%0.7 M๐Ÿ‡บ๐Ÿ‡ธ USA